Forte Biosciences, Inc. ( FBRX) - Key Metrics
FBRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.98 | $0.79 | $0.79 |
| 2026Q1 | $0 | -$1.24 | -$1.05 | -$1.05 |
| 2025Q4 | $0 | -$1.39 | -$0.92 | -$0.92 |
| 2025Q3 | $0 | -$0.99 | -$0.79 | -$0.79 |
| 2025Q2 | $0 | -$0.96 | -$0.86 | -$0.86 |
FBRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.48 |
| 2026Q1 | 0% | -5.22 |
| 2025Q4 | 0% | -4.90 |
| 2025Q3 | 0% | -3.79 |
| 2025Q2 | 0% | -3.37 |
FBRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.72% | 0% |
| 2026Q1 | -4.07% | 0% |
| 2025Q4 | -3.38% | 0% |
| 2025Q3 | -5.27% | 0% |
| 2025Q2 | -6.63% | 0% |
FBRX
Price: $76.83
52 week price:
Earnings Per Share: -4.57 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 50864
Market Capitalization: 1.6 billion